Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects
Recruiting
Phase 2
Interventional Study
Occlusion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 64
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 20 (estimated)
- Sponsor
- Rutgers, The State University of New Jersey · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The proposed pilot study is aimed at preliminary characterization of the TMNB injection in 20 healthy volunteers. Assessment of bite-force distribution and surface electromyographic activity of the temporalis and the masseter muscles, at rest and clench, before and after unilateral TMNB injection, will be the primary outcome measures. Post-injection assessments will be performed at 30 minutes, 2 h…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18-64 years of age
* All ethnicity
* Male and female sex
* Fluent in written/spoken English
* Never been diagnosed with TMD
* No significant history of orofacial pain
* \<5 headaches/month in the 3 months before enrollment
* No reported use of a nightguard or occlusal splint '…
Contacts